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Abstract We have studied phospholipase D activation in
[32P]orthophosphoric acid-prelabeled rat pancreatic acini by
measuring the formation of 32P-phosphatidylalcohols as stimu-
lated in the presence of ethanol or butanol. A small but signif-
icant and time-dependent basal accumulation of [32P]phos-
phatidylethanol and [32P]phosphatidylbutanol was detected,
which was further stimulated by phorbol myristate acetate,
orthovanadate and pervanadate. However, the secretagogues
cholecystokinin octapeptide and carbachol did not enhance basal
accumulation of 32P-phosphatidylalcohol, yet they decreased
[32P]phosphatidylcholine content and stimulated the generation
of [32P]phosphatidic acid. Our results stress the need to examine
the transphosphatidylation reaction as well as agonist effects on
the synthesis of phosphatidylcholine in order to assess unam-
biguously phospholipase D activity. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Pancreatic acini is a model system widely used to study
signaling mechanisms involved in the secretory pathway
[1,2]. Among other events, changes in the lipidic membrane
components may constitute an important step of the complex
secretory machinery [3]. In this context, cholecystokinin
CCKA and muscarinic receptor activation in pancreatic acini
have been shown to trigger phospholipid hydrolysis through
phosphoinositide phospholipase C [2], phosphatidylcholine
phospholipase C [4,5] and phospholipase A2 [1].
Phospholipase D (PLD) has been suggested to play a role in
exocytotic pathways in di¡erent systems such as chroma⁄n
cells [6], HL60 cells [7], neutrophils [8], neurons [9] or yeast
[10]. Furthermore, the PLD1 isoenzyme may be a candidate to
regulate secretion because of its localization in secretory gran-
ules [11]. The ability of this enzyme to catalyze the transphos-
phatidylation reaction in the presence of a primary alcohol
prevents the formation of its immediate lipid product phos-
phatidate, producing instead the corresponding phosphatidyl-
alcohol, which is rather stable metabolically and accumulates
in membranes. There are various reports in the literature de-
scribing slight but signi¢cant activations of PLD by CCKA
agonists [12,13], the protein kinase C activator phorbol myr-
istate acetate (PMA) [14], and several growth factors acting
through tyrosine kinase activation [15]. In most of these
works, the experimental design consisted of labeling pancre-
atic acini with [3H]myristic acid, which incorporates preferen-
tially to phosphatidylcholine [16,17]. The fact that phosphati-
dylcholine is the main substrate for PLD makes [3H]myristic
acid a suitable phospholipid marker in this kind of study.
However, the lipidic nature of [3H]myristic acid and its recov-
ery in the chloroform phase after extraction of breakdown
products may enhance the background noise of the experi-
ments, and this could become critical when a slight activation
of PLD is to be detected.
In this work, we have used the water soluble radiochemical
marker [32P]orthophosphate to measure the accumulation of
32P-phosphatidylalcohol in prelabeled rat pancreatic acini
challenged with a variety of stimuli. Simultaneously, we
measured the changes in [32P]phosphatidylcholine and
[32P]phosphatidate labeling. CCK-8 (cholecystokinin octapep-
tide (26^33), Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-
NH2) and carbachol (Cch) did not stimulate PLD, but pro-
moted [32P]phosphatidate formation and a reduction in
[32P]phosphatidylcholine. In contrast, PMA, orthovanadate
and pervanadate clearly stimulated PLD and did not alter
[32P]phosphatidylcholine labeling.
2. Materials and methods
We purchased CCK-8 from Peninsula Laboratories (Belmont, CA,
USA), [32P]orthophosphoric acid (carrier free) from DuPont New
England Nuclear (ITISA, Madrid, Spain), and puri¢ed collagenase
(type CLSPA) from Worthington Biochemical Corporation (Lake-
wood, NJ, USA). Soybean trypsin inhibitor (type II-S), BME amino
acids solution, BME vitamins solution, Cch, PMA, orthovanadate,
H2O2 and phospholipid standards were from Sigma (St. Louis, MO,
USA), and silica gel-60 thin layer chromatography (TLC) plates from
Merck (Barcelona, Spain). All other chemicals used were of analytical
grade.
2.1. Tissue preparation
Wistar rats (200^250 g) were killed by cervical dislocation and dis-
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persed pancreatic acini were isolated by collagenase digestion accord-
ing to the modi¢cations [18] of the procedure published previously
[19]. Unless otherwise indicated, the standard incubation solution
contained: 25 mM HEPES (pH adjusted to 7.45 with concentrated
NaOH), 98 mM NaCl, 6 mM KCl, 5 mM sodium pyruvate, 6 mM
sodium fumarate, 5 mM sodium L-glutamate, 11.5 mM glucose, 2 mM
KH2PO4, 1.2 mM MgCl2, 0.5 mM CaCl2, 2 mM L-glutamine, 1%
(w/v) soybean trypsin inhibitor, 1% (w/v) amino acid mixture, 1%
(v/v) vitamin mixture, and 1% (w/v) bovine serum albumin. The in-
cubation solution was equilibrated with 100% O2, which consisted of
the gas phase in all the incubations performed.
2.2. Labeling of pancreatic acini with [32P]orthophosphate
Prior to stimulation, pancreatic acini from one rat were suspended
in 4 ml of the HEPES bu¡ered incubation solution detailed above,
without added phosphate, in a £at bottomed £ask. One hundred WCi/
ml of [32P]orthophosphate were added to the acini suspension and it
was incubated for 2 h at 37‡C. Then, acini were washed by centrifu-
gation and resuspended with the same fresh incubation solution in a
¢nal volume of 6 ml. In 100 Wl of this ¢nal solution the amount of
[32P]Pi incorporated into phospholipids averaged 7751 þ 562 dpm,
which was divided into four phospholipid classes (phosphatidate,
12 þ 3%; phosphatidylethanolamine, 8 þ 1%; phosphatidylcholine,
64 þ 7%; phosphatidylinositol 16 þ 1%).
2.3. Measurement of PLD activity
PLD was assayed by measuring the formation of 32P-phosphatidyl-
alcohol by the PLD-catalyzed transphosphatidylation reaction in the
presence of a primary alcohol, as described previously [20]. One hun-
dred Wl aliquots of the [32P]orthophosphate-labeled acini suspension
were transferred into tubes containing agonists, and/or a primary
alcohol and other additions, when indicated to a ¢nal volume of
250 Wl and incubated at 37‡C for 1 h unless otherwise stated. At
the end of incubation 1.2 ml chloroform/methanol (1:2, v/v) were
added to stop the reaction. After 30 min on ice, 0.5 ml each of chloro-
form and water were added, and the tubes shaken vigorously. After a
5 min centrifugation at 2000Ug, the upper (aqueous) phases were
removed, and the lower (organic) phases containing 32P-lipids were
washed with 1.55 ml methanol/water (1:1 v/v). Aliquots (0.6 ml) of
the washed organic phases were centrifuged under vacuum to evapo-
rate the solvent. To separate [32P]phosphatidylalcohol from the rest of
the 32P-lipids, the lipidic pellets were resuspended in 15 Wl chloroform/
methanol (4:1, v/v) and spotted onto silica gel-60 TLC plates that
were developed with chloroform/methanol/acetic acid (65:15:2, by
vol.) [20]. When simultaneous measuring of 32P-phosphatidylalcohol
and [32P]phosphatidylcholine was required, the major 32P-phospholip-
id classes were separated in TLC plates developed with the mixture
chloroform/methanol/acetone/acetic acid/water (50:10:20:10:5, by
vol.) as mobile phase. In both cases the areas corresponding to phos-
phatidylethanol and phosphatidylbutanol were identi¢ed with authen-
tic standards after staining with I2 vapor. Radioactivity in the TLC
plates was quanti¢ed by means of a Packard Instant Imager system.
Background values were taken as the radioactivity present in the areas
corresponding to either phosphatidylalcohol in samples incubated in
the absence of alcohol and was subtracted from all values, unless
indicated otherwise (Fig. 2a).
3. Results
Fig. 1 shows the time course of phosphatidylcholine label-
ing with [32P]orthophosphate. After an initial 60 min period of
recovery, labeling was approximately linear up to 3 h under
control conditions. It is worth noting that the rate of
[32P]orthophosphate incorporation into PtdCho did not de-
cline during the last hour of incubation under control condi-
tions, although free [32P]orthophosphate tracer was washed
from the acini suspension prior to this period. However, ad-
dition of 1 nM CCK-8 or 100 WM Cch resulted in a clear
decrease in the rate of phosphatidylcholine labeling. This re-
duction was accompanied by concomitant increases in phos-
phatidylinositol (10-fold, not shown) and phosphatidate label-
ing (see below), due most probably to the activation of the
phosphoinositide cycle, as ¢rst described by Hokin and Hokin
[21].
In order to ascertain whether this agonist-induced decrease
of phosphatidylcholine labeling is mirrored by the activation
of phosphatidylcholine PLD, we challenged [32P]orthophos-
phate-labeled acini with agonists in the presence of 200 mM
ethanol, and measured the appearance of [32P]phosphatidyl-
ethanol and [32P]phosphatidate. As shown in Fig. 2a, there
was a small but linear and signi¢cant increase of [32P]phos-
phatidylethanol up to 1 h of incubation under basal condi-
tions, but neither CCK-8 nor Cch stimulated this accumula-
tion further. Since dpm values for [32P]phosphatidylethanol
were very low, Fig. 2a also shows the background noise,
which is a time-independent value, consisting of the radioac-
tivity measured by the detection system in the TLC area cor-
responding to phosphatidylethanol from samples obtained in
the absence of ethanol (10 þ 2 dpm, n = 32). On the other
hand, both 1 nM CCK-8 and 100 WM Cch were able to in-
crease rapidly the accumulation of [32P]phosphatidate, which
reached a plateau after 10 min (Fig. 2b). It is important to
note here that [32P]phosphatidate levels were not reduced due
to the presence of ethanol (not shown), suggesting that the
generation of this lipid is entirely due to phosphorylation of
phosphoinositide phospholipase C-generated diacylglycerol.
Taken together, these results show the absence of any signi¢-
cant stimulation of PLD by 1 nM CCK-8 or 100 WM Cch
under the conditions used, i.e. 200 mM ethanol, which is the
alcohol concentration most commonly used in PLD experi-
ments.
In order to explore further the feasibility of testing PLD
activity in pancreatic acini, we tried di¡erent concentrations
of alcohol, ethanol and butanol, as nucleophilic acceptors for
the transphosphatidylation reaction (not shown). In these ex-
periments basal accumulation of [32P]phosphatidylethanol or
[32P]phosphatidylbutanol was clearly dependent on the alco-
hol concentration, reaching maximal values of 33 þ 6 and
52 þ 8 dpm at around 200 mM ethanol and 25 mM butanol,
Fig. 1. Time course of [32P]phosphatidylcholine labeling. Pancreatic
acini were incubated with 100 WCi/ml [32P]orthophosphate under
control conditions (open circles) or in the presence of 1 nM CCK-8
(¢lled triangles) or 100 WM Cch (¢lled circles), which were added
after 120 min, then radioactivity in phosphatidylcholine was deter-
mined. Results are means þ S.E.M. of three independent experiments
run with triplicate determinations.
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respectively. However, CCK-8 did not promote any signi¢cant
increase of either 32P-phosphatidylalcohol, yet control experi-
ments showed that ethanol or butanol concentrations up to
500 or 50 mM, respectively, did not a¡ect CCK-8-induced
release of amylase (not shown). Again, these results point
towards the absence of PLD stimulation by CCK-8, although
they con¢rm the presence of a small but signi¢cant basal PLD
activity in rat pancreatic acini.
We performed the next series of experiments in order to
measure the radioactivity present in 32P-phosphatidylalcohol
and [32P]phosphatidylcholine in the same sample, as described
in Section 2. In this case the stimuli used were 100 WM Cch,
1 nM CCK-8 and 100 nM PMA. Table 1 shows the accumu-
lation of [32P]phosphatidylethanol and [32P]phosphatidyl-
butanol, expressed as absolute radioactivity in each lipid,
and also as a percentage of [32P]phosphatidylcholine. Accu-
mulation of [32P]phosphatidylethanol and [32P]phosphatidyl-
butanol was signi¢cantly higher than the controls only in
the case of PMA, but not with CCK-8 or Cch. On the other
hand, unlike CCK-8 and Cch, PMA did not decrease labeling
of phosphatidylcholine.
Fig. 2. Time course of [32P]phosphatidylethanol (a) and [32P]phos-
phatidate (b) increase in rat pancreatic acini. [32P]Orthophosphate-
labeled pancreatic acini were incubated for the times indicated with
100 WM Cch (¢lled circles), 1 nM CCK-8 (¢lled triangles) or under
basal conditions (open circles). Incubations were carried out in the
presence of 200 mM ethanol, except in background control samples,
which are also shown in (a) for comparison (diamonds). Results are
mean þ S.E.M. of three independent experiments carried out with
determinations in triplicate.
Fig. 3. 32P-Phospholipid changes after stimulation with vanadate
and pervanadate. Prelabeled acini were incubated for 1 h with
0.25 mM hydrogen peroxide, 0.25 mM orthovanadate or the combi-
nation of both additions to produce pervanadate, then radioactivity
in phosphatidylethanol (a), phosphatidate (b), and phosphatidylcho-
line (c) was determined. Results are mean þ S.E.M. of at least three
independent experiments carried out with triplicate determinations.
*P6 0.05 compared to basal (unpaired, two-tailed t-test).
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Our results disagree with those previously reported, which
were obtained using a [3H]myristic acid labeling design. As
this tracer incorporates mostly into phosphatidylcholine
[14,22], the inhibitory e¡ect of CCK-8 and Cch on phospha-
tidylcholine labeling (Fig. 1 and Table 1) may well account for
the apparent PLD stimulations reported before: as phospha-
tidylalcohol accumulation is usually expressed as percentage
of radioactivity in phosphatidylcholine or in the total lipid
fraction, this index may give false positive results, as illus-
trated in Table 1.
To further assess the absence of PLD stimulation by CCK-
8 and Cch in acini, we assayed di¡erent agonist concentra-
tions (not shown). These experiments resulted in Cch and
CCK-8 concentration-dependent increases of [32P]phospha-
tidate and decreases of [32P]phosphatidylcholine but, again,
[32P]phosphatidylethanol remained unaltered. These experi-
ments con¢rmed that the agonist-induced changes in
[32P]phosphatidate or [32P]phosphatidylcholine are independ-
ent of [32P]phosphatidylethanol levels, and therefore of PLD
activity.
Finally, with the aim of testing the e¡ects of stimuli other
than receptor agonists or direct PKC stimulation on PLD
activity, we used the Tyr-phosphatase inhibitors orthovana-
date and pervanadate. The results obtained in these experi-
ments are presented in Fig. 3, which shows a signi¢cant en-
hancement of [32P]phosphatidylethanol accumulation induced
by either 0.25 mM orthovanadate and pervanadate, made
after the mixture of 0.25 mM orthovanadate with 0.25 mM
hydrogen peroxide (Fig. 3a), in agreement with Rivard et al.
[22]. Fig. 3 also shows [32P]phosphatidate and [32P]phos-
phatidylcholine content in the same samples (panels b and c,
respectively). Interestingly, orthovanadate and pervanadate
elicited only a slight increase over basal of [32P]phosphatidate,
as compared to CCK-8 and Cch (Fig. 2b), and, unlike the two
receptor agonists, they did not modify [32P]phosphatidyl-
choline labeling. These data show that both orthovanadate
and pervanadate stimulate PLD in rat pancreatic acini, stress-
ing again that this stimulation is not mirrored by a concom-
itant increase in [32P]phosphatidate and/or decrease in
[32P]phosphatidylcholine.
4. Discussion
We have assayed the formation of phosphatidylalcohols as
an index to detect CCK-8 or Cch stimulation of PLD in rat
pancreatic acini, and our experiments have not revealed any
signi¢cant di¡erence in [32P]phosphatidylethanol or [32P]phos-
phatidylbutanol accumulation between basal and agonist-
stimulated samples. We observed however a net increase of
[32P]phosphatidylethanol when acini were stimulated by the
protein kinase C activator PMA (two-fold), or the Tyr-phos-
phatase inhibitors orthovanadate (two-fold) and pervanadate
(six-fold), which, in addition to its own signi¢cance, validates
the experimental approach used in this work to unambigu-
ously detect PLD activity. Interestingly, PLD stimulation by
PMA or vanadate was not accompanied by a concomitant
reduction of phosphatidylcholine labeling, providing a reason-
able clue for the agreement of our results with previously
published reports [14,22].
The fact that the percent ratios 32P-phosphatidylalcohol
versus [32P]phosphatidylcholine corresponding to CCK-8 or
Cch stimulation were higher than basal, was somehow surpris-
ing at the beginning. However, we provide evidence to show
that these di¡erences are due to a reduction of [32P]phos-
phatidylcholine rather than a net accumulation of 32P-phos-
phatidylalcohol. Other authors have already described a
decrease of [3H]myristic acid incorporation into [3H]phos-
phatidylcholine [23], probably due to an inhibition of the syn-
thesizing pathway [24]. Consequently, taking into account
that [3H]myristic acid incorporates preferentially to phospha-
tidylcholine, the reduction in labeling of this lipid may give
rise to a misleading interpretation regarding PLD responsive-
ness if data on 3H-phosphatidylalcohol accumulation are nor-
malized as a percentage of [3H]phosphatidylcholine or total
3H-phospholipids.
As [32P]orthophosphate incorporates into PtdCho through
the Kennedy pathway, our data indicate that reduction in
[32P]phosphatidylcholine labeling is presumably due to inhibi-
tion of the ‘de novo’ pathway of phosphatidylcholine synthe-
sis. In agreement with this observation, evidence has appeared
in the last few years showing that inhibition of phosphatidyl-
choline synthesis is not merely a response to CCK-8 and Cch
in pancreatic acini. Apoptosis triggered by di¡erent cellular
insults in a variety of cell preparations is preceded by inhibi-
tion of the Kennedy pathway [25^28]. Also, it has been shown
recently that excitotoxic neuronal death is preceded by inhi-
bition of phosphatidylcholine synthesis [29], a phenomenon
that is accompanied by a release of choline to the extracellular
medium [29,30].
In a good number of the ¢rst reports on PLD stimulation,
reviewed in [31], the experimental design consisted of a
[3H]choline-prelabeling period followed by the detection of
[3H]choline released to the medium and/or the accumulation
of intracellular 3H-choline metabolites. Thus, under the light
Table 1
Accumulation of [32P]phosphatidylethanol ([32P]PtdEtOH) and [32P]phosphatidylbutanol ([32P]PtdButOH), expressed as absolute radioactivity
(dpm) or as percentage of [32P]phosphatidylcholine ([32P]PtdCho) in each sample
Ethanol Butanol
[32P]PtdEtOH
(dpm)
[32P]PtdCho
(dpm)
[32P]PtdEtOH
(% of [32P]PtdCho)
[32P]PtdButOH
(dpm)
[32P]PtdCho
(dpm)
[32P]PtdButOH
(% of [32P]PtdCho)
Basal 32 þ 4 8784 þ 318 0.36 þ 0.05 35 þ 6 10223 þ 301 0.34 þ 0.06
1 nM CCK-8 34 þ 3 6896 þ 291a 0.49 þ 0.04a 36 þ 2 7409 þ 271a 0.49 þ 0.03a
100 WM Cch 35 þ 2 6794 þ 55a 0.52 þ 0.03a 37 þ 2 7631 þ 181a 0.48 þ 0.03a
100 nM PMA 55 þ 2a 8802 þ 165 0.62 þ 0.02a 72 þ 3a 10197 þ 290 0.71 þ 0.03a
[32P]Pi-prelabeled rat pancreatic acini were incubated during 1 h in the presence of 200 mM ethanol or 25 mM butanol without any further ad-
dition (basal), or with 100 WM Cch, 1 nM CCK-8, or 100 nM PMA. Results are mean þ S.E.M. of three independent experiments with tripli-
cate determinations.
aP6 0.05 compared to basal (unpaired, two-tailed t-test).
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of the apparently widespread phenomenon of inhibition of
phosphatidylcholine synthesis, some of those reports might
have to be re-examined, as it is becoming increasingly clear
that the observation of 3H-choline release does not necessarily
re£ect activation of PLD.
All together, our results show that the observed reduction
of [32P]phosphatidylcholine triggered by CCK-8 and Cch in
pancreatic acini does not re£ect PLD activation, as there is no
net accumulation of 32P-phosphatidylalcohol, the increase of
[32P]phosphatidate most likely being a consequence of phos-
phoinositide^phospholipase C activation by the same ago-
nists. In conclusion, our work argues against an involvement
of PLD on CCK-8 and Cch mediated responses in pancreatic
acinar cells. Furthermore, our study lends some experimental
support to the contention that inhibition of phosphatidylcho-
line synthesis could be taken into account as another signaling
mechanism switched on by secretagogues, which might take
part in their physiological e¡ects.
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